Waltham, MA 11/10/08—PerkinElmer has announced that it will refocus its business into two areas, Human Health and Environmental Health, beginning January 1, 2009. The Human Health business will include the company’s Genetic Screening, Bio-discovery and Medical Imaging operating units and will be led on an interim basis by company President and CEO Robert Friel. The […]
Although electronic lab notebooks (ELNs) have been steadily replacing paper lab notebooks for almost a decade, their acceptance in chemistry-based disciplines has far outweighed their use in biological research. A basic ELN is a device or software that is able to store various laboratory data types, from calculations to notes prepared by researchers. The data […]
Major pharmaceutical companies, including GlaxoSmithKline (GSK), Eli Lilly and Roche, are increasing their research operations in China. China offers scientific talent, many contract research organizations (CROs), lower costs and a fast-growing drug market. By 2020, the country is predicted to be the world’s second largest drug market. For many of these companies, China offers a […]
After 30 years, and a 2005 court order, last month, the US EPA finalized new primary and secondary national ambient air quality standards (NAAQS) for lead. The new primary and secondary standards for lead each tighten the limits of concentrated lead from 1.5 µg/m3 to 0.15 µg/m3 . The primary standard is the standard set […]
Santa Clara, CA 11/11/08—Affymetrix has agreed to acquire Panomics, a provider of assay products, for $73 million in cash. Panomics offers products for low to mid-plex genetic, protein and cellular analysis applications that enable a direct assay approach that does not require nucleic acid extraction or amplification. “Panomics presented a great opportunity for Affymetrix to […]
In the third quarter of 2008, revenues for IBO’s Laboratory Instrument Sales Index slowed to a growth rate of 8.1%, reaching $4,576 million, while operating profits grew 15.1% to $778 million, and operating margin climbed 100 basis points to 17.0% of sales. Despite strong revenue growth from Illumina, Luminex and QIAGEN NV, other companies such […]
The European Commission has proposed a revision to the EU’s Protocol on Animal Welfare that is intended to unify standards across all member states and to update the legislation. Among the proposals is the requirement that alternative testing methods be used when available and that the use of animals be reduced to the minimum necessary. […]
It was another year when one major deal in the analytical instrument and laboratory products industry dwarfed the size of other deals. Invitrogen’s $6.7 billion acquisition of Applied Biosystems was this year’s mega-deal, bringing together the largest supplier of life science consumables with one of the largest supplier of instruments for life science research (see […]
Company Announcements Hudson Control Group named Dr. Alan H. Katz chief scientific officer. Previously, he led Wyeth Research’s computation chemistry and drug design group. PaR Systems, a provider of specialized material handling and automation equipment, was acquired in July by MML Capital and PaR Systems management. BioTrove opened an office in San Carlos, California, in […]
The Industrial Research Institute reports that R&D spending by one thousand leading US R&D firms rose 9.9% last year to $216,951.8 million, down from 12.1% growth in 2006. Sales for the firms rose 7.4% last year to $4,999,500.5 million, resulting in R&D totaling 4.3% of sales. R&D as a percentage of profit was 37.9%, as […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
